养血清脑丸联合倍他司汀治疗后循环缺血性眩晕疗效观察及对血液流变学指标的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R255.3

基金项目:


Curative Observation of Yangxue Qingnao Pills Combined with Betahistine for Vertigo Due to Posterior Circulation Ischemia and Its Effect on Hemorheology Indexes
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察养血清脑丸联合倍他司汀治疗后循环缺血性眩晕的临床疗效及对血液流变学指标的影 响。方法:按照随机数字表法将118 例后循环缺血性眩晕患者分为对照组和观察组各59 例。对照组给予甲磺 酸倍他司汀片治疗,观察组在对照组的基础上给予养血清脑丸治疗。2 组均连续治疗2 周。比较2 组血液流变 学指标[血浆黏度(PV)、全血黏度(WBV)、纤维蛋白原(Fib)]、双椎动脉(VA) 和基底动脉(BA) 血流 速度、中医证候积分、临床疗效以及不良反应发生率。结果:观察组总有效率为91.52%,明显高于对照组 72.88%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组PV、WBV、Fib 水平均较治疗前降低(P< 0.05),且观察组PV、WBV、Fib 水平均低于对照组(P<0.05)。治疗后,2 组VA、BA 血流速度均较治疗前 升高(P<0.05);且观察组VA、BA 血流速度均高于对照组(P<0.05)。治疗后,2 组头晕目眩、恶心呕吐、 倦怠乏力、耳鸣耳聋、头重如蒙等中医证候评分均较治疗前降低(P<0.05),且观察组各项证候评分均低于对 照组(P<0.05)。观察组不良反应发生率为6.78%,对照组为11.87%,2 组比较,差异无统计学意义(P> 0.05)。结论:养血清脑丸联合倍他司汀治疗后循环缺血性眩晕疗效显著,能够明显改善血液流变学状态、椎 动脉血流速度及临床症状,且不良反应相对较少。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Yangxue Qingnao Pills combined with Betahistine for vertigo due to posterior circulation ischemia and its effect on hemorheology indexes. Methods:A total of 118 cases of patients with vertigo due to posterior circulation ischemia were divided into the control group and the observation group according to the random number table method,with 59 cases in each group. The control group was treated with Betahistine Mesilate Tablets, and the observation group was additionally given oral administration of Yangxue Qingnao Pills based on the treatment of the control group. Both groups were treated for 2 weeks. The levels of hemorheology indexes including plasma viscosity (PV),whole blood viscosity (WBV) and fibrinogen (FIB),the blood flow velocity of vertebral artery (VA) and basilar artery (BA), the traditional Chinese medicine syndrome scores, the clinical effects and the incidence of adverse reactions were compared between the two groups. Results: The total effective rate was 91.52% in the observation group, significantly higher than that of 72.88% in the control group, the difference being significant (P<0.05). After treatment,the levels of PV,WBV and Fib in the two groups were decreased when compared with those before treatment (P<0.05), and the levels of PV, WBV and Fib in the observation group were lower than those in the control group (P<0.05). After treatment, the blood flow velocity of VA and BA in the two groups was increased when compared with that before treatment (P< 0.05),and the blood flow velocity of VA and BA in the observation group was higher than that in the control group (P<0.05). After treatment, the syndrome scores including dizziness and dizzy vision, nausea and vomiting,fatigue and hypodynamia,tinnitus and deafness,and heaviness of head in the two groups were decreased when compared with those before treatment (P<0.05), and the syndrome scores in the observation group were lower than those in the control group (P<0.05). The rate of adverse reactions was 6.78% in the observation group and 11.87% in the control group, there being no significance in the difference (P>0.05). Conclusion: Yangxue Qingnao Pills combined with Betahistine has a significant curative effect in treating vertigo due to posterior circulation ischemia,which can significantly improve the hemorheology, blood flow velocity of vertebral arteries and clinical symptoms, with fewer adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

刘小倩,郭兰凯,张唯聪.养血清脑丸联合倍他司汀治疗后循环缺血性眩晕疗效观察及对血液流变学指标的影响[J].新中医,2023,55(10):23-26

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-05-25
  • 出版日期: